Treatment with Anakinra improves disposition index but not insulin sensitivity in nondiabetic subjects with the metabolic syndrome: a randomized, double-blind, placebo-controlled study.
J Clin Endocrinol Metab
; 96(7): 2119-26, 2011 Jul.
Article
in En
| MEDLINE
| ID: mdl-21508140
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Blood Glucose
/
Insulin Resistance
/
Metabolic Syndrome
/
Interleukin 1 Receptor Antagonist Protein
/
Hypoglycemic Agents
Type of study:
Clinical_trials
/
Diagnostic_studies
Limits:
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Clin Endocrinol Metab
Year:
2011
Document type:
Article
Affiliation country:
Netherlands